骨髓增生性疾病
医学
癌症研究
重症监护医学
生物
皮肤病科
病理
作者
Hugh Young Rienhoff,Harinder Gill
标识
DOI:10.1080/13543784.2023.2267980
摘要
In patients with MPNs, bomedemstat appears effective and well tolerated. The signs and symptoms of these diseases are managed as a reduction in the frequency of mutant cells was demonstrated in patients with ET and MF. Ongoing and planned studies of bomedemstat in MPN will establish the position of bomedemstat in MPNs and may help to redefine treatment endpoints of MPNs in the future.
科研通智能强力驱动
Strongly Powered by AbleSci AI